{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:51:17Z","timestamp":1791888677559,"version":"4.3.4"},"reference-count":51,"publisher":"Keio Journal of Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio j. med","Keio J. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2302\/kjm.2017-0019-ir","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T17:15:39Z","timestamp":1520270139000},"page":"57-66","source":"Crossref","is-referenced-by-count":13,"title":["Human Amniotic Fluid Stem Cells: Therapeutic Potential for Perinatal Patients with Intractable Neurological Disease"],"prefix":"10.2302","volume":"67","author":[{"given":"Daigo","family":"Ochiai","sequence":"first","affiliation":[{"name":"Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Otani","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Fukutake","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Miyakoshi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1082","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Uccelli A, Moretta L, Pistoia V: Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726\u2013736. PMID:19172693, DOI:10.1038\/nri2395","DOI":"10.1038\/nri2395"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Roubelakis MG, Bitsika V, Zagoura D, Trohatou O, Pappa KI, Makridakis M, Antsaklis A, Vlahou A, Anagnou NP: In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. J Cell Mol Med 2011; 15: 1896\u20131913. PMID:21166769, DOI:10.1111\/j.1582-4934.2010.01180.x","DOI":"10.1111\/j.1582-4934.2010.01180.x"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25: 100\u2013106. PMID:17206138, DOI:10.1038\/nbt1274","DOI":"10.1038\/nbt1274"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tsai MS, Lee JL, Chang YJ, Hwang SM: Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004; 19: 1450\u20131456. PMID:15105397, DOI:10.1093\/humrep\/deh279","DOI":"10.1093\/humrep\/deh279"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315\u2013317. PMID:16923606, DOI:10.1080\/14653240600855905","DOI":"10.1080\/14653240600855905"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Perin L, Sedrakyan S, Da Sacco S, De Filippo R: Characterization of human amniotic fluid stem cells and their pluripotential capability. 2008; 86: 85\u201399.","DOI":"10.1016\/S0091-679X(08)00005-8"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Phermthai T, Odglun Y, Julavijitphong S, Titapant V, Chuenwattana P, Vantanasiri C, Pattanapanyasat K: A novel method to derive amniotic fluid stem cells for therapeutic purposes. BMC Cell Biol 2010; 11: 79. PMID:20955626, DOI:10.1186\/1471-2121-11-79","DOI":"10.1186\/1471-2121-11-79"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Loukogeorgakis SP, De Coppi P: Concise Review: Amniotic fluid stem cells: the known, the unknown, and potential regenerative medicine applications. Stem Cells 2017; 35: 1663\u20131673. PMID:28009066, DOI:10.1002\/stem.2553","DOI":"10.1002\/stem.2553"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Calvin SE, Oyen ML: Microstructure and mechanics of the chorioamnion membrane with an emphasis on fracture properties. Ann N Y Acad Sci 2007; 1101: 166\u2013185. PMID:17332077, DOI:10.1196\/annals.1389.009","DOI":"10.1196\/annals.1389.009"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Hoehn H, Bryant EM, Karp L, Martin GM: Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. I. Clonal morphology and growth potential. Pediatr Res 1974; 8: 746\u2013754. PMID:4844525, DOI:10.1203\/00006450-197408000-00003","DOI":"10.1203\/00006450-197408000-00003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zhang S, Geng H, Xie H, Wu Q, Ma X, Zhou J, Chen F: The heterogeneity of cell subtypes from a primary culture of human amniotic fluid. Cell Mol Biol Lett 2010; 15: 424\u2013439. PMID:20499195, DOI:10.2478\/s11658-010-0017-1","DOI":"10.2478\/s11658-010-0017-1"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Eckert MA, Vu Q, Xie K, Yu J, Liao W, Cramer SC, Zhao W: Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke. J Cereb Blood Flow Metab 2013; 33: 1322\u20131334. PMID:23756689, DOI:10.1038\/jcbfm.2013.91","DOI":"10.1038\/jcbfm.2013.91"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Madrigal M, Rao KS, Riordan NH: A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med 2014; 12: 260. PMID:25304688, DOI:10.1186\/s12967-014-0260-8","DOI":"10.1186\/s12967-014-0260-8"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Yang DY, Sheu ML, Su HL, Cheng FC, Chen YJ, Chen CJ, Chiu WT, Yiin JJ, Sheehan J, Pan HC: Dual regeneration of muscle and nerve by intravenous administration of human amniotic fluid-derived mesenchymal stem cells regulated by stromal cell-derived factor-1\u03b1 in a sciatic nerve injury model. J Neurosurg 2012; 116: 1357\u20131367. PMID:22503125, DOI:10.3171\/2012.2.JNS111360","DOI":"10.3171\/2012.2.JNS111360"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Pan HC, Cheng FC, Chen CJ, Lai SZ, Lee CW, Yang DY, Chang MH, Ho SP: Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. J Clin Neurosci 2007; 14: 1089\u20131098. PMID:17954375, DOI:10.1016\/j.jocn.2006.08.008","DOI":"10.1016\/j.jocn.2006.08.008"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Pan HC, Yang DY, Chiu YT, Lai SZ, Wang YC, Chang MH, Cheng FC: Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell. J Clin Neurosci 2006; 13: 570\u2013575. PMID:16769515, DOI:10.1016\/j.jocn.2005.06.007","DOI":"10.1016\/j.jocn.2005.06.007"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Rehni A, Singh N, Jaggi A, Singh M: Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice. Behav Brain Res 2007; 183: 95\u2013100. PMID:17619060, DOI:10.1016\/j.bbr.2007.05.028","DOI":"10.1016\/j.bbr.2007.05.028"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Tajiri N, Acosta S, Glover LE, Bickford PC, Jacotte Simancas A, Yasuhara T, Date I, Solomita MA, Antonucci I, Stuppia L, Kaneko Y, Borlongan CV: Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. PLoS One 2012; 7: e43779. PMID:22912905, DOI:10.1371\/journal.pone.0043779","DOI":"10.1371\/journal.pone.0043779"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Liu T, Wu J, Huang Q, Hou Y, Jiang Z, Zang S, Guo L: Human amniotic epithelial cells ameliorate behavioral dysfunction and reduce infarct size in the rat middle cerebral artery occlusion model. Shock 2008; 29: 603\u2013611. PMID:18414234","DOI":"10.1097\/shk.0b013e318157e845"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Broughton BR, Lim R, Arumugam TV, Drummond GR, Wallace EM, Sobey CG: Post-stroke inflammation and the potential efficacy of novel stem cell therapies: focus on amnion epithelial cells. Front Cell Neurosci 2013; 6: 66. PMID:23335880, DOI:10.3389\/fncel.2012.00066","DOI":"10.3389\/fncel.2012.00066"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. MacDonald HM, Mulligan JC, Allen AC, Taylor PM: Neonatal asphyxia. I. Relationship of obstetric and neonatal complications to neonatal mortality in 38,405 consecutive deliveries. J Pediatr 1980; 96: 898\u2013902. PMID:7365599, DOI:10.1016\/S0022-3476(80)80574-9","DOI":"10.1016\/S0022-3476(80)80574-9"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Gunn AJ: Cerebral hypothermia for prevention of brain injury following perinatal asphyxia. Curr Opin Pediatr 2000; 12: 111\u2013115. PMID:10763759, DOI:10.1097\/00008480-200004000-00004","DOI":"10.1097\/00008480-200004000-00004"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Ferriero DM: Neonatal brain injury. N Engl J Med 2004; 351: 1985\u20131995. PMID:15525724, DOI:10.1056\/NEJMra041996","DOI":"10.1056\/NEJMra041996"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Vannucci R: Hypoxic-ischemic encephalopathy. Am J Perinatol 2000; 17: 113\u2013120. PMID:11012134, DOI:10.1055\/s-2000-9293","DOI":"10.1055\/s-2000-9293"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Hasegawa J, Toyokawa S, Ikenoue T, Asano Y, Satoh S, Ikeda T, Ichizuka K, Tamiya N, Nakai A, Fujimori K, Maeda T, Masuzaki H, Suzuki H, Ueda S, Prevention recurrence committee, Japan obstetric compensation system for cerebral palsy: Relevant obstetric factors for cerebral palsy: From the nationwide obstetric compensation system in Japan. PLoS One 2016; 11: e0148122. PMID:26821386, DOI:10.1371\/journal.pone.0148122","DOI":"10.1371\/journal.pone.0148122"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Reid SM, Carlin JB, Reddihough DS: Rates of cerebral palsy in Victoria, Australia, 1970 to 2004: has there been a change? Dev Med Child Neurol 2011; 53: 907\u2013912. PMID:21752018, DOI:10.1111\/j.1469-8749.2011.04039.x","DOI":"10.1111\/j.1469-8749.2011.04039.x"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Tr\u00f8nnes H, Wilcox AJ, Lie RT, Markestad T, Moster D: Risk of cerebral palsy in relation to pregnancy disorders and preterm birth: a national cohort study. Dev Med Child Neurol 2014; 56: 779\u2013785. PMID:24621110, DOI:10.1111\/dmcn.12430","DOI":"10.1111\/dmcn.12430"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ: Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005; 365: 663\u2013670. PMID:15721471, DOI:10.1016\/S0140-6736(05)17946-X","DOI":"10.1016\/S0140-6736(05)17946-X"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH, National Institute of Child Health and Human Development Neonatal Research Network: Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353: 1574\u20131584. PMID:16221780, DOI:10.1056\/NEJMcps050929","DOI":"10.1056\/NEJMcps050929"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Johnston MV, Fatemi A, Wilson MA, Northington F: Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol 2011; 10: 372\u2013382. PMID:21435600, DOI:10.1016\/S1474-4422(11)70016-3","DOI":"10.1016\/S1474-4422(11)70016-3"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Nitkin CR, Bonfield TL: Concise review: Mesenchymal stem cell therapy for pediatric disease: perspectives on success and potential improvements. Stem Cells Transl Med 2017; 6: 539\u2013565. PMID:28191766, DOI:10.5966\/sctm.2015-0427","DOI":"10.5966\/sctm.2015-0427"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Bennet L, Tan S, Van den Heuij L, Derrick M, Groenendaal F, van Bel F, Juul S, Back SA, Northington F, Robertson NJ, Mallard C, Gunn AJ: Cell therapy for neonatal hypoxia-ischemia and cerebral palsy. Ann Neurol 2012; 71: 589\u2013600. PMID:22522476, DOI:10.1002\/ana.22670","DOI":"10.1002\/ana.22670"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Titomanlio L, Kavelaars A, Dalous J, Mani S, El Ghouzzi V, Heijnen C, Baud O, Gressens P: Stem cell therapy for neonatal brain injury: Perspectives and challenges. Ann Neurol 2011; 70: 698\u2013712. PMID:22162055, DOI:10.1002\/ana.22518","DOI":"10.1002\/ana.22518"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Fleiss B, Guillot PV, Titomanlio L, Baud O, Hagberg H, Gressens P: Stem cell therapy for neonatal brain injury. Clin Perinatol 2014; 41: 133\u2013148. PMID:24524451, DOI:10.1016\/j.clp.2013.09.002","DOI":"10.1016\/j.clp.2013.09.002"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Shinoyama M, Ideguchi M, Kida H, Kajiwara K, Kagawa Y, Maeda Y, Nomura S, Suzuki M: Cortical region-specific engraftment of embryonic stem cell-derived neural progenitor cells restores axonal sprouting to a subcortical target and achieves motor functional recovery in a mouse model of neonatal hypoxic-ischemic brain injury. Front Cell Neurosci 2013; 7: 128. PMID:23970853, DOI:10.3389\/fncel.2013.00128","DOI":"10.3389\/fncel.2013.00128"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ: Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun 2010; 24: 387\u2013393. PMID:19883750, DOI:10.1016\/j.bbi.2009.10.017","DOI":"10.1016\/j.bbi.2009.10.017"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Meier C, Middelanis J, Wasielewski B, Neuhoff S, Roth-Haerer A, Gantert M, Dinse HR, Dermietzel R, Jensen A: Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res 2006; 59: 244\u2013249. PMID:16439586, DOI:10.1203\/01.pdr.0000197309.08852.f5","DOI":"10.1203\/01.pdr.0000197309.08852.f5"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Pimentel-Coelho PM, Rosado-de-Castro PH, Barbosa da Fonseca LM, Mendez-Otero R: Umbilical cord blood mononuclear cell transplantation for neonatal hypoxic\u2013ischemic encephalopathy. Pediatr Res 2012; 71: 464\u2013473. PMID:22430382, DOI:10.1038\/pr.2011.59","DOI":"10.1038\/pr.2011.59"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Liao Y, Cotten M, Tan S, Kurtzberg J, Cairo MS: Rescuing the neonatal brain from hypoxic injury with autologous cord blood. Bone Marrow Transplant 2013; 48: 890\u2013900. PMID:22964590, DOI:10.1038\/bmt.2012.169","DOI":"10.1038\/bmt.2012.169"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Cotten CM, Murtha AP, Goldberg RN, Grotegut CA, Smith PB, Goldstein RF, Fisher KA, Gustafson KE, Waters-Pick B, Swamy GK, Rattray B, Tan S, Kurtzberg J: Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J Pediatr 2014; 164: 973\u2013979 e1.","DOI":"10.1016\/j.jpeds.2013.11.036"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Copp AJ, Adzick NS, Chitty LS, Fletcher JM, Holmbeck GN, Shaw GM: Spina bifida. Nat Rev Dis Primers 2015; 1: 15007. PMID:27189655, DOI:10.1038\/nrdp.2015.7","DOI":"10.1038\/nrdp.2015.7"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Danzer E, Zhang L, Radu A, Bebbington MW, Liechty KW, Adzick NS, Flake AW: Amniotic fluid levels of glial fibrillary acidic protein in fetal rats with retinoic acid induced myelomeningocele: a potential marker for spinal cord injury. Am J Obstet Gynecol 2011; 204: 178 e1-11.","DOI":"10.1016\/j.ajog.2010.09.032"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43. Adzick NS, Thom EA, Spong CY, Brock JW, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D\u2019Alton ME, Farmer DL, MOMS Investigators: A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011; 364: 993\u20131004. PMID:21306277, DOI:10.1056\/NEJMoa1014379","DOI":"10.1056\/NEJMoa1014379"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44. Li H, Gao F, Ma L, Jiang J, Miao J, Jiang M, Fan Y, Wang L, Wu D, Liu B, Wang W, Lui VC, Yuan Z: Therapeutic potential of in utero mesenchymal stem cell (MSCs) transplantation in rat foetuses with spina bifida aperta. J Cell Mol Med 2012; 16: 1606\u20131617. PMID:22004004, DOI:10.1111\/j.1582-4934.2011.01470.x","DOI":"10.1111\/j.1582-4934.2011.01470.x"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Li H, Miao J, Zhao G, Wu D, Liu B, Wei X, Cao S, Gu H, Zhang Y, Wang L, Fan Y, Yuan Z: Different expression patterns of growth factors in rat fetuses with spina bifida aperta after in utero mesenchymal stromal cell transplantation. Cytotherapy 2014; 16: 319\u2013330. PMID:24364908, DOI:10.1016\/j.jcyt.2013.10.005","DOI":"10.1016\/j.jcyt.2013.10.005"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Lee DH, Kim EY, Park S, Phi JH, Kim SK, Cho BK, Lim J, Wang KC: Reclosure of surgically induced spinal open neural tube defects by the intraamniotic injection of human embryonic stem cells in chick embryos 24 hours after lesion induction. J Neurosurg 2006; 105(Suppl): 127\u2013133. PMID:16922074","DOI":"10.3171\/ped.2006.105.2.127"},{"key":"47","doi-asserted-by":"publisher","unstructured":"47. Lee DH, Park S, Kim EY, Kim SK, Chung YN, Cho BK, Lee YJ, Lim J, Wang KC: Enhancement of re-closure capacity by the intra-amniotic injection of human embryonic stem cells in surgically induced spinal open neural tube defects in chick embryos. Neurosci Lett 2004; 364: 98\u2013100. PMID:15196686, DOI:10.1016\/j.neulet.2004.04.033","DOI":"10.1016\/j.neulet.2004.04.033"},{"key":"48","doi-asserted-by":"publisher","unstructured":"48. Dionigi B, Ahmed A, Brazzo J, Connors JP, Zurakowski D, Fauza DO: Partial or complete coverage of experimental spina bifida by simple intra-amniotic injection of concentrated amniotic mesenchymal stem cells. J Pediatr Surg 2015; 50: 69\u201373. PMID:25598096, DOI:10.1016\/j.jpedsurg.2014.10.004","DOI":"10.1016\/j.jpedsurg.2014.10.004"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49. Dionigi B, Brazzo JA, Ahmed A, Feng C, Wu Y, Zurakowski D, Fauza DO: Trans-amniotic stem cell therapy (TRASCET) minimizes Chiari-II malformation in experimental spina bifida. J Pediatr Surg 2015; 50: 1037\u20131041. PMID:25929798, DOI:10.1016\/j.jpedsurg.2015.03.034","DOI":"10.1016\/j.jpedsurg.2015.03.034"},{"key":"50","doi-asserted-by":"publisher","unstructured":"50. Feng C, D Graham C, Connors JP, Brazzo J, Brazzo J 3rd, Zurakowski D, Fauza DO: A comparison between placental and amniotic mesenchymal stem cells for transamniotic stem cell therapy (TRASCET) in experimental spina bifida. J Pediatr Surg 2016; 51: 1010\u20131013. PMID:27013425, DOI:10.1016\/j.jpedsurg.2016.02.071","DOI":"10.1016\/j.jpedsurg.2016.02.071"},{"key":"51","doi-asserted-by":"publisher","unstructured":"51. Turner CG, Pennington EC, Gray FL, Ahmed A, Teng YD, Fauza DO: Intra-amniotic delivery of amniotic-derived neural stem cells in a syngeneic model of spina bifida. Fetal Diagn Ther 2013; 34: 38\u201343. PMID:23635813, DOI:10.1159\/000350267","DOI":"10.1159\/000350267"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/67\/4\/67_2017-0019-IR\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T03:06:52Z","timestamp":1570849612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/67\/4\/67_2017-0019-IR\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.2017-0019-ir","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"value":"0022-9717","type":"print"},{"value":"1880-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}